The ability of Y010913, Y010916, and FSHR323 antibodies to stain the paraffin-embedded Flp-In CHO/FSHR cells and human cancer tissues was tested at Indivumed, a German integrated oncology company leveraging its leading oncology biorepository expertise with its pre-clinical, clinical, and diagnostic laboratory expertise. This evidence concerns the gene FSHR and cancer.